ICLR (Icon Plc) Stock Analysis - AI Report

Icon Plc (ICLR) is a publicly traded Healthcare sector company. As of May 21, 2026, ICLR trades at $115.09 with a market cap of $8.69B and a P/E ratio of 0.00. ICLR moved +1.51% today. Year to date, ICLR is -41.75%; over the trailing twelve months it is -12.86%. Its 52-week range spans $66.57 to $303.69. Analyst consensus is buy with an average price target of $135.57. Rallies surfaces ICLR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on ICLR?

Rallies AI research for ICLR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

ICLR Key Metrics

Key financial metrics for ICLR
MetricValue
Price$115.09
Market Cap$8.69B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$303.69
52-Week Low$66.57
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ICLR News

ICLR Analyst Consensus

8 analysts cover ICLR: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $135.57.

Common questions about ICLR

What is the AI research view on ICLR?
Rallies AI research for ICLR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for ICLR?
Rallies AI research for ICLR combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is ICLR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ICLR. It does not provide personalized investment advice.
ICLR

ICLR